Scalper1 News
Valeant’s CEO (and stock) hospitalized. Constant Contact runs into SEC trouble. What to do about “window dressing”. In the current episode, we discuss Valeant (NYSE: VRX ) and Constant Contact (NASDAQ: CTCT ) as well as ways to exploit yearend window dressing. Scalper1 News
Scalper1 News